Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Dysfunction
Pergolide ameliorates nocturia in female Parkinson disease patients
May 13th, 2004
Pergolide ameliorates nocturia in female Parkinson disease patients. According to researchers in Japan, "we started the subject screening from over 400 patients with Parkinson disease using strict selection criteria to identify the patients with nocturia who would allow accurate and efficient evaluation of the pergolide effects. The subjects were confined to female patients to exclude patients with potential prostate hypertrophy. "The patients treated with bromocriptine at 7.5-15 mg/day adjunctive to L-dopa were selected to replace bromocriptine with pergolide of the equivalent dosage approved in Japan. The nocturia was defined as having more than...
Source: Women's Health Weekly (2004-05-13)
|
